Zhejiang Shengda Bio-Pharm Co., Ltd. (SHA:603079)
China flag China · Delayed Price · Currency is CNY
12.70
-0.38 (-2.91%)
Sep 10, 2026, 3:00 PM CST

SHA:603079 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
544.06457.67315.62323.72320.72514.75
Short-Term Investments
-10.5830-1020.07
Trading Asset Securities
40.07182.060.013.01-0.01
Cash & Short-Term Investments
584.13650.31345.63326.74330.72534.83
Cash Growth
14.79%88.15%5.78%-1.20%-38.16%-6.40%
Accounts Receivable
166.82159.06141.24119.26135.9133.38
Other Receivables
20.950.370.550.60.850.17
Receivables
187.77159.43141.79119.86136.75133.55
Inventory
221.52189.74197.54228.48292.06222.09
Other Current Assets
54.8210.9323.8120.0720.8328.35
Total Current Assets
1,0481,010708.77695.15780.36918.81
Property, Plant & Equipment
979.45894.67769.47674.77561.81579.96
Long-Term Investments
10.741.8621.0160.760.720.74
Goodwill
10.9110.9110.9110.9110.9110.91
Other Intangible Assets
201.29222.94225.58231.82218.2156.09
Long-Term Deferred Tax Assets
6.497.010.060.895.363.38
Long-Term Deferred Charges
0.981.956.168.674.236.87
Other Long-Term Assets
9.188.843.3536.2813.6468.06
Total Assets
2,2672,1991,7851,7191,6551,765

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
233.01143.16155.44129.61164151.33
Accrued Expenses
18.2745.8638.3133.8437.5736.03
Short-Term Debt
-0.7930.8294.7541.76167.39
Current Portion of Long-Term Debt
7.6560.110.14--
Current Portion of Leases
-0.320.80.30.590.59
Current Income Taxes Payable
9.094.653.382.985.043.21
Current Unearned Revenue
2.894.493.82.928.76.54
Other Current Liabilities
23.8441.4218.7130.937.8147.4
Total Current Liabilities
294.74246.7251.38295.45295.46412.5
Long-Term Debt
330.52317.75231144--
Long-Term Leases
0.18-0.49-0.30.87
Long-Term Unearned Revenue
8.236.786.655.467.586.95
Long-Term Deferred Tax Liabilities
3.794.433.714.288.437.53
Other Long-Term Liabilities
8.18.18.1---
Total Liabilities
645.56583.75501.34449.2311.78427.84

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
189.03189.03171.19171.19171.19171.19
Additional Paid-In Capital
912.9911.96669.19669.19669.19669.19
Retained Earnings
506.47504.68442.53423.26487.6480.09
Treasury Stock
-21.13-21.13-22.08-8.97--
Comprehensive Income & Other
0.17-----
Total Common Equity
1,5871,5851,2611,2551,3281,320
Minority Interest
34.2530.2523.1415.3115.4516.49
Shareholders' Equity
1,6221,6151,2841,2701,3431,337
Total Liabilities & Equity
2,2672,1991,7851,7191,6551,765

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
338.35324.86263.23239.242.65168.85
Net Cash (Debt)
245.79325.4582.487.54288.07365.98
Net Cash Growth
9.46%294.95%-5.86%-69.61%-21.29%-18.70%
Net Cash Per Share
1.331.830.480.521.652.13
Filing Date Shares Outstanding
185.02187.44169.32169.32171.19171.19
Total Common Shares Outstanding
185.02187.44169.32170.46171.19171.19
Working Capital
753.5763.71457.38399.69484.9506.32
Book Value Per Share
8.588.457.457.367.767.71
Tangible Book Value
1,3751,3511,0241,0121,0991,153
Tangible Book Value Per Share
7.437.216.055.946.426.74
Buildings
-304.63290.21279.73274.11272.42
Machinery
-666.22589.14528.41515.04479.2
Construction In Progress
-432.84335.96247.3293.3388.76